Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioNxt Solutions Inc
C.BNXT
Alternate Symbol(s):
BNXTF
Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active...
pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:BNXT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(55)
•••
FTTHFan
X
View Profile
View Bullboard History
Post by
FTTHFan
on Jan 19, 2021 3:16pm
great article
https://www.mmjreporter.com/3-big-biotech-disruptors-for-2021-41311
(2)
•••
Adwari
X
View Profile
View Bullboard History
Post by
Adwari
on Jan 19, 2021 7:25am
XPHY rapid PCR test will improve air travel
Currently airlines require a negative COVID-19 test result within 72 hours before flying. With Xphy treat kit, the test could be done at the airport on the day of travel. That would be remarkable. Go
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(20)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Jan 17, 2021 8:02pm
RE:RE:This is looking GREAT again!
It's a done deal then...100% slam dunk! You are looking at this share price for the last time.
(2)
•••
Adwari
X
View Profile
View Bullboard History
Comment by
Adwari
on Jan 17, 2021 11:18am
RE:This is looking GREAT again!
Of course there are no safety issues since is an external diagnostic test. All that is required for it to demonstrate high sensitivity (ability of a test to correctly identify patients with the
...more
(20)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Jan 12, 2021 3:20pm
This is looking GREAT again!
The co. said they would be on the market early this year with their rapid test breakthrough for the Gold Standard PCR test kit. European approval is a given as long as there are no safety issues
...more
(4)
•••
dogfather94
X
View Profile
View Bullboard History
Post by
dogfather94
on Jan 08, 2021 2:05pm
FDA approved test
https://www.stockwatch.com/News/Item?bid=U-b20210108005522-U:APDN-20210108&symbol=APDN®ion=U I wonder how this compares to xphyto? Have they applied for fda approval and why
...more
(55)
•••
FTTHFan
X
View Profile
View Bullboard History
Post by
FTTHFan
on Jan 07, 2021 4:58pm
article in Germany
https://www.irw-press.at/press_html.aspx?messageID=54994
(2)
•••
Adwari
X
View Profile
View Bullboard History
Post by
Adwari
on Dec 30, 2020 3:13pm
Please, XPHY
XPHY, please launch the comecialization of your rapid COVID-19 rapid PCR test as fast as possible before massive vaccination goes into effect others you will miss out.
(6)
•••
gemsearcher2
X
View Profile
View Bullboard History
Comment by
gemsearcher2
on Dec 18, 2020 10:57am
RE:RE:launch in European markets are planned for Q1 2021.
yes that is right... eom
(2)
•••
Adwari
X
View Profile
View Bullboard History
Comment by
Adwari
on Dec 17, 2020 7:48pm
RE:launch in European markets are planned for Q1 2021.
Q1 2021 is 1 January – 31 March, not April.
(6)
•••
gemsearcher2
X
View Profile
View Bullboard History
Comment by
gemsearcher2
on Dec 17, 2020 4:53pm
RE:launch in European markets are planned for Q1 2021.
I did not kow that q1 begins april 01.. really? Perhaps i am missing something but if so... then why are the last SEDAR quarterly reports for Q3 2020 that are dated as being filed Nov. 30,2020 shown
...more
(8)
•••
jenkinjt
X
View Profile
View Bullboard History
Post by
jenkinjt
on Dec 17, 2020 3:10pm
launch in European markets are planned for Q1 2021.
Still a long way off with "European regulatory approval and commercial product launch in European markets are planned for Q1 2021". Everyone realizes that Q1 2021 starts April 1st, 2021
...more
(2)
•••
Adwari
X
View Profile
View Bullboard History
Comment by
Adwari
on Dec 17, 2020 9:31am
RE:The news is out and it is EXCEPTIONAL.
PCR-based results in 25 minutes. Wonderful. I just hope they seek approval as soon as January 2021.
(6)
•••
gemsearcher2
X
View Profile
View Bullboard History
Comment by
gemsearcher2
on Dec 17, 2020 9:17am
RE:RE:The news is out and it is EXCEPTIONAL.
So they now have successful validation so in the next short timeframe and i particularly like this part: : "European regulatory approval and commercial product launch in European markets are
...more
(6)
•••
gemsearcher2
X
View Profile
View Bullboard History
Comment by
gemsearcher2
on Dec 17, 2020 9:09am
RE:The news is out and it is EXCEPTIONAL.
Was glad to read your message this morning!..really good news.. wow.. this can be such a huge help to so many people have a great day! WA
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden